Farmacia y Biotecnología archivos

SPAARx Announces Expansion to Leadership Team

13 agosto, 201313 agosto, 2013admin

Internacional (Marketwired, 13 de Agosto de 2013) The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, today announced that Kevin Alder will join the Association's leadership team as Chief Operating Officer. Alder will be responsible for directing the day-to-day operations of SPAARx which has quickly grown to thousands of members since its official launch this past spring.

Ogilvy CommonHealth Worldwide Promotes Four From Within Their NY and NJ Offices

13 agosto, 2013admin

Internacional (Marketwired, 13 de Agosto de 2013) Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior experts of Ogilvy & Mather (www.ogilvy.com), today announced the promotion of four employees in their New York and New Jersey offices.

ProMetic to Report Its Second Quarter 2013 Highlights and Financial Results and Hold Conference Call / Webcast

12 agosto, 2013admin

Internacional (Marketwired, 12 de Agosto de 2013) ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF) ("ProMetic" or the "Corporation") today announced that it will report its financial results for the second quarter ended June 30, 2013 on Wednesday August 14, 2013 after market trading hours.

ProMetic to Report Its Second Quarter 2013 Highlights and Financial Results and Hold Conference Call / Webcast

12 agosto, 2013admin

Internacional (Marketwired, 11 de Agosto de 2013) ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF) ("ProMetic" or the "Corporation") today announced that it will report its financial results for the second quarter ended June 30, 2013 on Wednesday August 14, 2013 after market trading hours.

Adamis Pharmaceuticals Announces Investor Update Conference Call

9 agosto, 2013admin

Internacional (Marketwired, 09 de Agosto de 2013) Adamis Pharmaceuticals Corp. (OTCQB: ADMP) ("the Company"), a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, will host an investor conference call on Tuesday, August 13, 2013 at 4:15pm ET to provide a business update concerning the Company's recent corporate developments. The Company's President and CEO, Dr. Dennis Carlo, will host the call.

Boston Therapeutics Reports Financial Results and Corporate Update for the Second Quarter and Six Months Ended June 30, 2013

9 agosto, 2013admin

Internacional (Marketwired, 09 de Agosto de 2013) Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a drug development company focused on complex carbohydrates to treat diabetes and inflammatory diseases, reports its financial results for the second quarter and six months ended June 30, 2013.

Quantros Safety Rx and Patient Safety Organization Solution Expands

9 agosto, 2013admin

Internacional (Marketwired, 09 de Agosto de 2013) Integration of Comprehensive Data Management System to Enhance Pharmacy Services and Maintain Superior Guest Experience Within Target Retail Chains

BUYINS.NET Issues Atossa Genetics SqueezeTrigger Report

8 agosto, 20138 agosto, 2013admin

Internacional (Marketwired, 08 de Agosto de 2013) Approximately 3.3 Million Shares Shorted Since December 2012; Short Squeeze Expected When Stock Closes Above $6.99 SqueezeTrigger Price

Algae Biomass Summit to Feature Latest Advances in Commercial Algae Production

8 agosto, 2013admin

Internacional (Marketwired, 08 de Agosto de 2013) Industry Leaders to Highlight Pathways to Commercial Production of Algae-Derived Fuel, Feed and Other Valuable Products

WorldCare Clinical Introduces New Service for Oncology Imaging Studies Involving Immune-Related Response Criteria (irRC)

8 agosto, 2013admin

Internacional (Marketwired, 08 de Agosto de 2013) New Service Enables Combination Tumor Assessments Using Both RECIST and irRC